Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-12-12 FMR LLC Conversion +2,188,869 2,841,896
2017-12-12 FMR LLC Conversion +45,035 2,886,931
2017-12-12 FMR LLC Conversion +112,590 2,999,521
2017-12-12 FMR LLC Conversion +808,013 1,049,072
2017-12-12 FMR LLC Conversion +16,624 1,065,696
2017-12-12 FMR LLC Conversion +41,561 1,107,257
2017-12-12 FMR LLC Conversion +24,240 31,471
2017-12-12 FMR LLC Conversion +498 31,969
2017-12-12 FMR LLC Conversion +1,246 33,215
2017-12-12 FMR LLC Conversion · Series A-1 Convertible Preferred Stock −2,188,869 0
2017-12-12 FMR LLC Conversion · Series A-1 Convertible Preferred Stock −808,013 0
2017-12-12 FMR LLC Conversion · Series A-1 Convertible Preferred Stock −24,240 0
2017-12-12 FMR LLC Conversion · Series A-2 Convertible Preferred Stock −45,035 0
2017-12-12 FMR LLC Conversion · Series A-2 Convertible Preferred Stock −16,624 0
2017-12-12 FMR LLC Conversion · Series A-2 Convertible Preferred Stock −498 0
2017-12-12 FMR LLC Conversion · Series B-1 Convertible Preferred Stock −112,590 0
2017-12-12 FMR LLC Conversion · Series B-1 Convertible Preferred Stock −41,561 0
2017-12-12 FMR LLC Conversion · Series B-1 Convertible Preferred Stock −1,246 0

Page 1 of 1 · 18 trades